Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Surg. Mar 27, 2014; 6(3): 38-41
Published online Mar 27, 2014. doi: 10.4240/wjgs.v6.i3.38
Published online Mar 27, 2014. doi: 10.4240/wjgs.v6.i3.38
Role of stenting in the palliation of gastroesophageal junction cancer: A brief review
Theodoros E Pavlidis, Efstathios T Pavlidis, Second Surgical Propedeutic Department, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, 54642 Thessaloniki, Greece
Author contributions: Pavlidis TE designed the research and wrote the paper; Pavlidis ET performed the research and analyzed the data.
Correspondence to: Theodoros E Pavlidis, MD, PhD, Professor, Second Surgical Propedeutic Department, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Konstantinoupoleos 49, A Samothraki 23, 54642 Thessaloniki, Greece. pavlidth@med.auth.gr
Telephone: +30-2310-992861 Fax: +30-2310-992932
Received: October 7, 2013
Revised: December 21, 2013
Accepted: January 17, 2014
Published online: March 27, 2014
Processing time: 162 Days and 18.8 Hours
Revised: December 21, 2013
Accepted: January 17, 2014
Published online: March 27, 2014
Processing time: 162 Days and 18.8 Hours
Core Tip
Core tip: The topic is interesting and this manuscript contains the most recent data briefly highlighting it. More than half of the patients with gastroesophageal junction cancer present with inoperable disease at the time of diagnosis so they need palliative treatment to relieve dysphagia and its consequences. Stent placement ensures good quality of life during the short survival time but it has some additional specific problems in this particular location.